Amgen Inc. (formerly Applied Molecular Genetics Inc.[2][3]) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.Amgen
(Founded 1983 as Applied Molecular Genetics)Synergen Inc
(Acq 1994)Kinetix Pharmaceuticals Inc
(Acq 2000)Immunex Corporation
(Acq 2002)Tularik Inc (Acq 2004)Abgenix Inc
(Acq 2006)Avidia Inc
(Acq 2006)Alantos Pharmaceuticals
(Acq 2007)Ilypsa Inc
(Acq 2007)Alantos Pharmaceuticals Holdings Inc
(Acq 2007)BioVex Group Inc
(Acq 2011)Laboratório Químico Farmacêutico Bergamo Ltda
(Acq 2011)Micromet Inc
(Acq 2012)Mustafa Nevzat İlaç
(Acq 2012)KAI Pharmaceuticals
(Acq 2012)deCODE genetics
(Acq 2012)Onyx Pharmaceuticals
(Acq 2013)NextCODE genetics
(Spun off 2013)Dezima Pharma
(Acq 2015)Catherex
(Acq 2015)
